Innocar 150 Injection
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Carboplatin (150mg)
Overview Innocar 150 Injection
Oncaspar 150 Injection treats ovarian and small cell lung cancers by inhibiting or reducing cancerous cell proliferation. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can have severe consequences. Therapeutic effects might not be evident for weeks or months; discontinue only upon your doctor's instruction. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. The medication can lower blood cell counts (red and white blood cells), increasing infection and bleeding risks. Report fever, sore throat, chills, unusual bleeding or bruising, or dark urine immediately. Regular blood tests are essential to monitor blood cell counts, heart function, liver health, and uric acid levels. Report any allergic reactions like skin rash, itching, or breathing difficulties. Inform your healthcare provider about all other medications you're taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding. Both partners should use effective contraception throughout treatment to prevent conception.
Primary Ingredients of Innocar 150 Injection
The provided information is insufficient.
Uses of Innocar 150 Injection
Cancers of the ovary and small-cell lung
Major Benefits of Innocar 150 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Innocar 150 Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Innocar 150 Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
How Innocar 150 Injection works:
Inocard 150 Injection is a cancer treatment that disrupts the genetic makeup (DNA and RNA) of cancerous cells, thereby halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Innocar 150 Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Innocar 150 Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administering Innocar 150 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Innocar 150 Injection can lead to reduced alertness, impaired vision, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Innocar 150 Injection cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Kidney function should be regularly monitored during treatment.
LiverSAFE IF PRESCRIBED
In individuals with hepatic impairment, Innocar 150 Injection is likely safe. Available evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Innocar 150 Injection :
Omit a scheduled Innocar 150 Injection? Seek your physician's advice.
Facts to Know About Innocar 150 Injection
| Label | Value |
|---|---|
| Type of Compound | Platinum-based compounds |
| Potential for Dependence | None. |
| Type of Treatment | Cancer-fighting drugs |
| Mechanism of Action | Platinum-based anti-cancer agents |
3,018 People bought this recently